Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
96 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 6 (6%) | |
Resolved: | 89 (93%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 5 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OMNIPAQUE 240 | 518MG | SOLUTION | Anticipated shortage | 2025-01-24 | 2025-02-05 | 248506 |
OMNISCAN | 287MG | SOLUTION | Resolved | 2024-12-16 | 2025-01-03 | 245818 |
MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-12-09 | 2024-12-31 | 245107 |
OMNISCAN | 287MG | SOLUTION | Resolved | 2024-11-18 | 2024-12-06 | 243409 |
MYOVIEW | 0.23MG | POWDER FOR SOLUTION | Resolved | 2024-10-28 | 2024-10-29 | 241364 |
MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-10-18 | 2024-11-05 | 240653 |
CERETEC | 0.5MG | POWDER FOR SOLUTION | Resolved | 2024-09-20 | 2024-09-25 | 238131 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-17 | 2024-09-28 | 237809 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-16 | 2024-09-21 | 237683 |
OMNISCAN | 287MG | SOLUTION | Resolved | 2024-08-26 | 2024-09-28 | 235933 |
MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-08-19 | 2024-08-31 | 235488 |
CERETEC | 0.5MG | POWDER FOR SOLUTION KIT | Resolved | 2024-07-15 | 2024-08-31 | 232992 |
CERETEC | 0.5MG | POWDER FOR SOLUTION | Resolved | 2024-07-15 | 2024-08-22 | 232987 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-05-28 | 2024-06-12 | 229037 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2024-05-06 | 2024-05-18 | 227151 |
MYOVIEW 30ML | 1.38MG | POWDER FOR SOLUTION | Resolved | 2024-05-02 | 2024-05-16 | 226858 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-04-23 | 2024-05-04 | 225946 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-03-11 | 2024-04-02 | 221863 |
VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-03-07 | 2024-03-14 | 221590 |
OMNIPAQUE 350 | 755MG | SOLUTION | Avoided shortage | 2024-01-30 | 2024-02-14 | 217731 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
Showing 1 to 5 of 5